Search Results - "Panitch, Hillel S"

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis by Schwid, Steven R., MD, Panitch, Hillel S., MD

“…Abstract Background: Interferon (IFN)-β therapy represents an important advance in the management of relapsing multiple sclerosis (MS), but information about…”
Get full text

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis by Schwid, Steven R, Panitch, Hillel S

“…Interferon (IFN)-beta therapy represents an important advance in the management of relapsing multiple sclerosis (MS), but information about the relative…”
Get full text

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis by Panitch, Hillel S., Thisted, Ronald A., Smith, Richard A., Wynn, Daniel R., Wymer, James P., Achiron, Anat, Vollmer, Timothy L., Mandler, Raul N., Dietrich, Dennis W., Fletcher, Malcolm, Pope, Laura E., Berg, James E., Miller, Ariel

“…Objective To evaluate the efficacy and safety of DM/Q (capsules containing dextromethorphan [DM] and quinidine [Q]) compared with placebo, taken twice daily,…”
Get full text

Investigational drug therapies of treatment of multiple sclerosis by Panitch, H S

“…The licensing of interferon beta-1b dramatically changed the treatment of multiple sclerosis (MS) in the United States. Although it was the first therapeutic…”
Get more information

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment by Rudick, Richard A, Goodman, Andrew, Herndon, Robert M, Panitch, Hillel S

Get full text

Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system by Panitch, Hillel S., Hirsch, Robert L., Schindler, John, Johnson, Kenneth P.

Get full text

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon [beta]-1a for relapsing multiple sclerosis by Schwid, Steven R, Panitch, Hillel S

“…Background: Interferon (IFN)-β therapy represents an important advance in the management of relapsing multiple sclerosis (MS), but information about the…”
Get full text

Interferon beta‐lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial

Get full text

Influence of infection on exacerbations of multiple sclerosis by Panitch, H S

“…Exacerbations of multiple sclerosis (MS) are triggered by exogenous events, the best documented being viral upper respiratory infections (URIs), which can…”
Get more information

Experimental Allergic Encephalomyelitis: Enhancement of Cell-Mediated Transfer by Concanavalin A by Panitch, Hillel S, McFarlin, Dale E

“…Adoptive transfer of experimental allergic encephalomyelitis (EAE) with splenic lymphocytes from Lewis rats sensitized to myelin basic protein (BP) was…”
Get full text

T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis by Panitch, H S, Francis, G S

Get more information

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis by Petkau, A John, White, Richard A, Ebers, George C, Reder, Anthony T, Sibley, William A, Lublin, Fred D, Paty, Donald W

“…We have analysed data on exacerbation rates, Expanded Disability Status Scale (EDSS) scores, and lesion burdens using the results of two neutralizing antibody…”
Get full text

Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment by Dix, R D, Baringer, J R, Panitch, H S, Rosenberg, S H, Hagedorn, J, Whaley, J

“…A 54-year-old man developed clinical findings consistent with herpes simplex virus (HSV) encephalitis. These signs included an abrupt onset of focal central…”
Get more information

Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro by Hirsch, Robert L., Panitch, Hillel S., Johnson, Kenneth P.

Get full text

Progressive rubella panencephalitis. Late onset after congenital rubella by Townsend, J J, Baringer, J R, Wolinsky, J S, Malamud, N, Mednick, J P, Panitch, H S, Scott, R A, Oshiro, L, Cremer, N E

“…In children with congenital rubella infection the deficits remain stable; neurologic deterioration after the first few years of life is not believed to occur…”
Get more information

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system by Panitch, H S, Hirsch, R L, Schindler, J, Johnson, K P

“…We treated 18 clinically definite relapsing-remitting MS patients with recombinant gamma interferon in a pilot study designed to evaluate toxicity and dosage…”
Get full text

Systemic alpha-interferon in multiple sclerosis. Long-term patient follow-up by Panitch, H S

“…Twelve patients with relapsing multiple sclerosis who had participated in a clinical trial of systemic (subcutaneous) natural alpha-interferon were interviewed…”
Get more information

Interferons in multiple sclerosis : a review of the evidence by PANITCH, H. S

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system, characterised clinically by relapses and remissions, and…”
Get full text

Elevation of serum creatine phosphokinase in amyotrophic later a1 sclerosis by Panitch, Hillel S., Franklin, Gary M.

Get full text

CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis by Panitch, H S, Hooper, C J, Johnson, K P

“…A solid phase radioimmunoassay was used to detect antibodies to myelin basic protein (MBP) in the CSF of patients with multiple sclerosis (MS) and subacute…”
Get more information